Why I Don't Recommend Ozempic Anymore (And What To Use Instead)

#GLP1 #Ozempic #Semaglutide #Tirzepatide #Retatrutide #WeightLoss

If you searched for Ozempic, Wegovy, or semaglutide, you're trying to figure out whether this drug makes sense for you.

Semaglutide is the weight loss drug everyone has heard of. It's what your doctor knows, what the media talks about, and what insurance is most likely to cover. But it may not be the best option for you anymore.

In this video, I break down exactly how semaglutide works, why 39 to 45 percent of the weight you lose can be muscle, and what the newer drugs do differently at the receptor level.

You'll learn about:

• How GLP-1 receptor agonists actually work in your body
• What the 68 week clinical trial data shows about semaglutide (15% average weight loss)
• Why losing muscle damages your metabolism in the process of trying to fix it
• What happens when you stop taking semaglutide (two thirds regain within one year)
• How tirzepatide activates two receptors and preserves significantly more muscle
• The head to head trial data comparing semaglutide vs tirzepatide (47% more weight loss)
• What retatrutide does differently with its triple receptor activation
• Why the newer drugs address fat loss from multiple angles instead of just appetite suppression
• The foundations that determine whether your results last: protein, training, and sleep

⚠️ Disclaimer: This video is for informational purposes only and not medical advice. Always consult your physician before starting any medication.

⏱️ Chapters

0:00 Is semaglutide right for you
0:55 How semaglutide works (GLP-1 mechanism)
2:40 Semaglutide does not burn fat directly
2:55 Clinical trial results (15% weight loss in 68 weeks)
3:50 The muscle loss problem (39-45% of weight lost)
4:20 Why losing muscle damages your metabolism
5:00 Weight regain after stopping semaglutide
6:00 Is there something better
6:10 Tirzepatide explained (dual receptor)
6:45 Semaglutide vs tirzepatide head to head data
7:20 Why tirzepatide preserves more muscle
7:50 Retatrutide explained (triple agonist)
8:25 Retatrutide phase 3 trial results (28.7% weight loss)
9:15 Why more receptors means better fat loss
9:45 Which GLP-1 drug I recommend now
10:30 Protein, training, and sleep foundations
11:15 Free community and resources

💉 Free Peptide & Supplement Tracker App: Calculate your doses, track your consistency, and log how you feel:

https://tracker.joshholyfield.com

🔗 Want peptide research, safe sourcing strategies, training programs, and nutrition coaching? Join my FREE Skool community:

For men: https://www.skool.com/jh-iron-forge-b...
For women: https://www.skool.com/powerhouse-pept...

📋 Looking for personalized coaching and accountability?

https://programs.theironforge.us/survey

Drop your questions in the comments, and subscribe for more real-world insights on peptides, supplements, and sustainable fat loss.

Tags / Keywords (for algorithm)

glp-1, ozempic, wegovy, semaglutide, tirzepatide, mounjaro, zepbound, retatrutide, ozempic weight loss, semaglutide muscle loss, ozempic vs tirzepatide, glp-1 comparison, semaglutide results, tirzepatide results, retatrutide weight loss, glp-1 side effects, ozempic muscle, weight loss drugs, semaglutide vs tirzepatide, best glp-1 for fat loss, ozempic body composition, weight loss peptides, glp-1 receptor agonist, dual agonist, triple agonist

____________________

Socials:

Facebook:   / joshholyfieldpd  
Instagram:   / josh.holyfield  
TikTok:   / josh_holyfield  
Youtube:    / joshholyfieldfitness  
Blog: https://joshholyfield.com/blogs/news

======================================================

©Josh Holyfield - For all business inquiries contact josh@joshholyfield.com

This video is not to be reproduced without prior authorization. The original YouTube video may be distributed & embedded if required.